Pinealon

Pinealon is a tripeptide (Glu-Asp-Arg) derived from the pineal gland peptide complex identified through the extensive Russian peptide bioregulator research programme led by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It represents the pineal gland's regulatory peptide component in the same family of organ-specific short peptides that includes Epithalon (thymus/epiphysis), Vilon (thymus), Cortagen (cortex), and Retinalamine (retina).

The theoretical framework underlying the Russian peptide bioregulator programme is that short peptide sequences derived from specific organs can selectively regulate gene expression in those same organ types - essentially acting as epigenetic modulators that help restore youthful patterns of gene expression in aged or damaged tissue. For Pinealon, this means peptide sequences that selectively modulate neuronal gene expression, particularly in the context of the pineal gland and central nervous system.

Research into Pinealon has documented several consistent biological activities across in vitro and in vivo models. Neuroprotective effects have been demonstrated in models of ischaemic brain injury and neuronal hypoxia, where Pinealon reduces cell death and promotes survival signalling. In neural stem cell research, the peptide promotes proliferation and differentiation of neuronal precursor cells - a finding relevant to neurogenesis research.

Cognitive effects in aged animal models are among the most notable findings. Aged rodents treated with Pinealon show improvements in spatial memory tasks, learning speed, and cognitive flexibility compared to untreated aged controls. These improvements have been attributed to both neuroprotective effects (preserving existing neurons) and neurogenic effects (supporting new neuron formation).

The pineal gland connection gives Pinealon relevance to circadian biology research. The pineal gland is the primary production site of melatonin and plays a central role in circadian rhythm entrainment. Research suggests Pinealon can influence pineal gland function and melatonin production, making it relevant to sleep research and circadian disruption models.

Anti-oxidative properties are well-documented - Pinealon reduces markers of oxidative stress in neuronal tissue, including lipid peroxidation products and ROS accumulation. This anti-oxidative activity may contribute to its protective effects in brain ageing models.

The peptide is typically used in intranasal form to facilitate CNS penetration. Intranasal delivery accesses the olfactory nerve pathway that bypasses the blood-brain barrier, allowing direct peptide delivery to olfactory bulb tissue and subsequent distribution to connected brain regions. This route has become the standard for CNS-targeted peptide research where systemic administration would result in poor CNS penetration.